前列腺MRI定量成像:AJR定量成像特别系列
本文综述前列腺MRI定量成像技术。DWI的ADC是临床意义前列腺癌及治疗后复发癌的强效判别生物标志物。先进扩散技术、T1/T2衍生指标、DCE及病灶大小形状特征结合影像组学与人工智能,但哪项技术广泛临床应用取决于多平台验证。
要点
- DWI的ADC对临床意义前列腺癌及治疗后复发癌有强判别价值。
- 先进扩散技术判别力似更优但技术挑战更大。
- 定量病灶大小与形状特征可结合影像组学与人工智能进一步优化。
核心结论
- 前列腺MRI传统依赖定性判读,定量成分有潜力显著提升性能。
- ADC是应用最广的定量MRI生物标志物,对临床意义前列腺癌和治疗后复发癌有强判别价值。
- 先进扩散技术、T1/T2衍生指标、DCE及病灶大小形状特征结合影像组学与人工智能,但最终广泛临床应用取决于多平台验证。
研究设计与样本
- 综述,属于AJR定量成像特别系列。
- 原文未报告检索范围与纳入文献数量。
诊断标准与关键数值
- ADC是应用最广的定量MRI生物标志物,对临床意义前列腺癌及治疗后复发癌有强判别价值。
- 先进扩散技术包括体素内不相干运动成像、扩散峰度成像、扩散张量成像及限制谱成像等特定实现,声称判别力更优但技术挑战更大。
- 组织固有T1和T2提供诊断价值,更先进技术可导出管腔水分数和混合多维MRI指标。
- 动态对比增强成像主要使用改良Tofts模型,也显示独立判别价值。
临床应用与阅片要点
- 原文未据此给出推荐。
局限性
- 先进扩散技术虽然声称判别力更优,但技术挑战更大。
- 哪项技术最终广泛临床应用取决于在众多平台和使用场景中的验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Prostate MRI has traditionally relied on qualitative interpretation. However, quantitative components hold the potential to markedly improve performance. The ADC from DWI is probably the most widely recognized quantitative MRI biomarker and has shown strong discriminatory value for clinically significant prostate cancer as well as for recurrent cancer after treatment. Advanced diffusion techniques, including intravoxel incoherent motion imaging, diffusion kurtosis imaging, diffusion-tensor imaging, and specific implementations such as restriction spectrum imaging, purport even better discrimination but are more technically challenging. The inherent T1 and T2 of tissue also provide diagnostic value, with more advanced techniques deriving luminal water fraction and hybrid multidimensional MRI metrics. Dynamic contrast-enhanced imaging, primarily using a modified Tofts model, also shows independent discriminatory value. Finally, quantitative lesion size and shape features can be combined with the aforementioned techniques and can be further refined using radiomics, texture analysis, and artificial intelligence. Which technique will ultimately find widespread clinical use will depend on validation across a myriad of platforms and use cases.
引用
- Margolis DJA, Chatterjee A, deSouza NM, et al. Quantitative Prostate MRI, From the AJR Special Series on Quantitative Imaging. AJR Am J Roentgenol. 2024. PMID: 39356481. doi:10.2214/AJR.24.31715
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。